Lack of Correlation of the Serum 25(OH) Vitamin D Levels with the Glycated Hemoglobin A1c and the Lipid Profile in Type 2 Diabetes Patients on Oral Antidiabetic Drugs – Preliminary Data

Open access

Summary

Data from different studies correlating the serum 25(OH)D levels with the metabolic and glycemic parameters in type 2 diabetes patients are still varying. The objective if this study was to describe the correlation between serum 25(OH)D levels and some metabolic parameters in Bulgarian type 2 diabetes patients on oral antidiabetic drugs. One hundred type 2 diabetes patients participated - 56 men and 44 women. The mean age and diabetes duration of the women was 59.0 and 9.8 years, of the men - 58.0 and 7.7 years respectively. Complete patient history was taken and physical examination was performed (body weight and height, waist circumference). Body composition was measured on a leg-to-leg body impedance analyzer (TBF-215, Tanita Corp., Tokyo, Japan). Serum levels of vitamin D were measured by electro-hemi-luminescent detection as 25-(ОН) D Total (ECLIA, Elecsys 2010, Roche Diagnostics, Switzerland). Glycated hemoglobin A1c was measured on a NycoCard reader (Alere™). Total, HDL-cholesterol (direct) and triglycerides were analyzed on a Cobas Integra 400+ analyzer. Correlation analysis was performed on a SPSS 13.0 for Windows platform and included 10 curves. The data were first analyzed for the group as a whole and then separately for men and women as well as in the different vitamin D tertiles. The mean serum 25-OH-vitamin D levels were 23.8 ± 12.1 nmol/l in women and 33.3 ± 20.0 nmol/l in men. We were unable to find any statistically significant correlation between serum 25(OH) vitaminand the serum lipids (cholesterol profile and triglycerides). On the contrary, there was a weak correlation with the glycated hemoglobin A1c (cubic model, R2 = 0.178, p = 0.05) and the BMI (inverse model, R2 = 0.101, p = 0.038). The sub-analyses (men versus women or according to tertiles of vitamin D) did not produce any additional information. The influence of vitamin D on the parameters of the metabolic control in type 2 diabetes is very weak on an individual level. It might be only demonstrated in large epidemiological surveys.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1 . Al - Shoume r K. A. et al. Does insulin resistance in type 2 diabetes alter vitamin D status? -Prim. Care Diabetes 7 2013 № 4 283-7.

  • 2 . Bakalov D. M. Boyanov A. Tsakova et al. Prevalence of deficiency and insufficiency of vitamin D in patients with type 2 diabetes mellitus on oral antidiabetic drugs. - Endocrinologia 18 2013 № 1 19-26. (article in Bulgarian).

  • 3 . Borissova А. М. et al. Frequency of vitamin D deficiency and insufficiency in the Bulgarian population ≥ 20-80 years. - Endocrinologia 17 2012 № 3 122-134 (article in Bulgarian).

  • 4 . Borissova A-M. Ts. Tankova G. Kirilov et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. - Int. J. Clin. Pract. 57 2003 № 4 258-261.

  • 5 . Calle C. M. Begoña et M. García-Arencibia. Genomic actions of 125-dihydroxyvitamin D3 on insulin receptor gene expression insulin receptor number and insulin activity in the kidney liver and adipose tissue of streptozotocin-induced diabetic rats. - BMC Molecular Biology 9 2008 65.

  • 6 . Chacko S. A. Y. Song J. E. Manson et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. - Am. J. Clin. Nutr. 94 2011 № 1 209-217.

  • 7 . Ganji V. et al. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. - Am. J. Clin. Nutr. 94 2011 №1 225-233.

  • 8 . George P. S. E. R. Pearson et M. D. Witham. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. - Diabet. Med. 29 2012 № 8 e142-50.

  • 9 . Gradinaru D. et al. Vitamin D Status and Oxidative Stress Markers in Elderly with Impaired Fasting Glucose and Type 2 Diabetes Mellitus. - Aging Clin. Exp. Res. 24 2012 № 6 595-602.

  • 10 . Husemoen L. L. et al. Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study. - Diabetes Care 35 2012 № 8 1695-1700.

  • 11 . Hutchinson M. S. et al. Serum 25-hydroxyvitamin D levels in subjects with reduced glucose tolerance and type 2 diabetes - the Tromsø OGTT-study. - Int. J. Vitam. Nutr. Res. 81 2011 № 5 317-327.

  • 12 . Jorde R. et al. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. - Eur. J. Clin. Nutr. 64 2010 № 12 1457-1464.

  • 13 . Jorde R. et G. Grimnes. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. - Prog. Lipid Res. 50 2011 № 4 303-312.

  • 14 . Kampmann U. et al. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity beta cell function and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind randomized placebo-controlled trial. - Metabolism 63 2014 № 9 1115-1124.

  • 15 . Luo C. et al. Hypovitaminosis D in Chinese type 2 diabetes: Lack of impact on clinical metabolic status and biomarkers of cellular inflammation. - Diab. Vasc. Dis. Res. 6 2009 № 3 194-199.

  • 16 . Mc Gill A-T. et al. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. - Nutr. J. 7 2008 4.

  • 17 . Menon R. K. et al. The effects of vitamin D2 or D3 supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised doubleblind placebo-controlled trial. - BMC Public Health 13 2013 999.

  • 18 . Ministry of Health. Guideline for the diagnosis prevention and treatment of vitamin D deficiency and insufficiency. Bulgarian Societies of Rheumatology Endocrinology Pediatrics and Clinical Laboratory 2013 (in Bulgarian).

  • 19 . Nasri H. et al. Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized double-blind placebo controlled clinical trial. - J. Nephropathol. 3 2014 № 1 29-33.

  • 20 . Palomer X. et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. - Diab. Obes. Metab. 10 2008 № 3 185-197.

  • 21 . Pittas A.G. J. Lau F.B. Hu et B. Dawson-Hughes. The role of vitamin D and calcium in Type 2 Diabetes. A systematic review and meta-analysis. - J. Clin. Endocrinol. Metab. 92 2007 № 6 2017-2029.

  • 22 . Ponda M. P. et al. Vitamin D may not improve lipid levels: A serial clinical laboratory data study. - Circulation 126 2012 № 3 270-277.

  • 23 . Toxqui L. et al. Changes in blood pressure and lipid levels in young women consuming a vitamin D-fortified skimmed milk: A randomised controlled trial. - Nutrients 5 2013 № 12 4966-4977.

  • 24 . Yilmaz H. et al. Is vitamin D status a predictor of glycaemic regulation and cardiac complication in type 2 diabetes mellitus patients? - Diab. Metab. Syndr. 6 2012 № 1 28-31.

  • 25. Yu J. R. et al. Serum vitamin D status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus. - Chonnam Med. J. 48 2012 № 2 108-115. 26 . Zhao Y. et al. Association of vitamin D receptor gene polymorphisms with metabolic syndrome: a case-control design of population-based cross-sectional study in North China. - Lipids Health Disease 13 2014 129.

Search
Journal information
Cited By
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 309 151 1
PDF Downloads 75 46 0